Agomab Therapeutics NV: Agomab Raises Additional $40.5 Milli

-- Extension led by Pfizer with participation from new investors Walleye Capital and Asabys Partners as well as existing investors -- -- Funding will support next stage of clinical and corporate development

Related Keywords

Kostenloser Wertpapierhandel , Laura Mittmann , Tim Knotnerus , Thomas Wynn , Michael Vincent , Pfizer , Redmile Group , Trophic Communications , Pfizer Breakthrough Growth Initiative , Walleye Capital , Asabys Partners , Vice President , Inflammation Immunology Discovery Biology , Scientific Advisory , Chief Executive Officer , Origo Biopharma , Senior Vice President , Chief Scientific Officer , Inflammation Immunology , Agomab Therapeutics , Agomab , Herapeutics , Raises , Dditional , Billion , Through , Series , Extension , Ringing , Total , Amount ,